From: Study protocol: MyoFit46—the cardiac sub-study of the MRC National Survey of Health and Development
Category | Pathology |
---|---|
Ventricular structure | Moderate-severe LV hypertrophy |
Ventricular function | Moderate-severe LV impairment |
Moderate-severe RV impairment | |
Atrial size | Moderate-severe atrial dilation |
Valvular pathology | Structural valve abnormalities e.g. bicuspid aortic valve |
Moderate-severe valvular stenosis | |
Moderate-severe valvular regurgitation | |
Pericardial effusion | Moderate-severe pericardial effusion |
Cardiac tamponade | |
Shunts | Ventricular septal defect |
Atrial septal defect | |
Cardiac masses | LV thrombus |
Intracardiac mass | |
Valvular mass e.g. vegetation/fibroelastoma | |
Myocardial inflammation | Acute/chronic myocardial inflammation |
Myocardial infarction | Acute/chronic myocardial infarction |
Myocardial fibrosis | Clinically significant LGE |
Perfusion defects | Clinically significant inducible perfusion defects |
Extra cardiac findings | Other suspected, significant or life-threatening finding |